当前位置:Public Access >页面
Chinese/English
A prospective,open-label, multicenter, randomized, Phase III trial to assess efficacy and safety of radical concurrent chemoradiotherapy alone versus radical concurrent chemoradiotherapy with consolidation chemotherapy for the locally advanced esophageal cancer.
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
200 Man 2023-02-09

In hospital

zyg
199 Man 2023-02-16

In hospital

zyg
198 Man 2023-02-09

In hospital

zyg
196 Woman 2023-04-10

In hospital

zyg
197 Man 2023-04-10

In hospital

zyg
191 Woman 2022-07-26

In hospital

zyg
190 Man 2022-05-24

In hospital

zyg
188 Man 2022-05-28

In hospital

zyg
195 Woman 2022-07-25

In hospital

zyg
192 Woman 2022-05-03

In hospital

zyg
189 Man 2022-05-09

In hospital

zyg
187 Man 2022-02-07

In hospital

zyg
194 Man 2022-06-06

In hospital

zyg
193 Woman 2022-06-07

In hospital

zyg
186 Man 2022-03-01

In hospital

zyg
185 Woman 2022-03-18

In hospital

zyg
184 Woman 2021-12-12 zyg
183 Man 2021-12-22

In hospital

zyg
182 Man 2021-12-07

In hospital

zyg
181 Man 2021-11-02

In hospital

zyg
180 Woman 2021-10-29

In hospital

zyg
179 Man 2021-11-01

Doctor's introduction

zyg
178 Man 2021-11-09

In hospital

zyg
177 Man 2021-10-15

In hospital

zyg
176 Man 2021-06-22

In hospital

zyg